Acrp Cambria Heights Elementary School Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 138 E Campbell St, Carrolltown, PA 15722 Phone: 814-535-2277 |
News Archive
A top Medicare official predicted Wednesday that the private Medicare Advantage program will continue to grow at double-digit rates, although payment reductions in the program are included in the health care overhaul law.
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
Young adults, a generally healthy population, are increasingly flocking to emergency departments instead of outpatient clinics for medical treatment. Young adults remain the most likely age group to lack health insurance and often lose their insurance during this pivotal transition period between adolescence and adulthood.
Transplantation of kidneys from Hepatitis C-infected donors to uninfected recipients is safe and can be successfully implemented as a standard of care, according to an observational study by physicians at the University of Tennessee Health Science Center and the James D. Eason Transplant Institute at Methodist University Hospital.
› Verified 2 days ago